These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis. Shah YM; Morimura K; Gonzalez FJ Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G657-66. PubMed ID: 17095756 [TBL] [Abstract][Full Text] [Related]
7. Yogurt starter cultures of Streptococcus thermophilus and Lactobacillus bulgaricus ameliorate symptoms and modulate the immune response in a mouse model of dextran sulfate sodium-induced colitis. Wasilewska E; Zlotkowska D; Wroblewska B J Dairy Sci; 2019 Jan; 102(1):37-53. PubMed ID: 30343915 [TBL] [Abstract][Full Text] [Related]
8. T cell PPARγ is required for the anti-inflammatory efficacy of abscisic acid against experimental IBD. Guri AJ; Evans NP; Hontecillas R; Bassaganya-Riera J J Nutr Biochem; 2011 Sep; 22(9):812-9. PubMed ID: 21109419 [TBL] [Abstract][Full Text] [Related]
9. Expression of PPAR γ in intestinal epithelial cells is dispensable for the prevention of colitis by dietary abscisic acid. Hontecillas R; Bassaganya-Riera J ESPEN J; 2012 Oct; 7(5):e189-e195. PubMed ID: 23814701 [TBL] [Abstract][Full Text] [Related]
10. mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile. Hu S; Chen M; Wang Y; Wang Z; Pei Y; Fan R; Liu X; Wang L; Zhou J; Zheng S; Zhang T; Lin Y; Zhang M; Tao R; Zhong J PLoS One; 2016; 11(4):e0154564. PubMed ID: 27128484 [TBL] [Abstract][Full Text] [Related]
12. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium. Pedersen G Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335 [TBL] [Abstract][Full Text] [Related]
13. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats. Celinski K; Dworzanski T; Korolczuk A; Piasecki R; Slomka M; Madro A; Fornal R J Physiol Pharmacol; 2011 Jun; 62(3):347-56. PubMed ID: 21893696 [TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor β activation ameliorates DSS-induced chronic colitis by inhibiting inflammation and promoting Treg differentiation. Guo D; Liu X; Zeng C; Cheng L; Song G; Hou X; Zhu L; Zou K Int Immunopharmacol; 2019 Dec; 77():105971. PubMed ID: 31678865 [TBL] [Abstract][Full Text] [Related]
15. Musculin Deficiency Aggravates Colonic Injury and Inflammation in Mice with Inflammatory Bowel Disease. Yu J; Liu Y; Zhang W; Yang X; Tang W; Liang H; Li S; Gao W; Yan J Inflammation; 2020 Aug; 43(4):1455-1463. PubMed ID: 32239394 [TBL] [Abstract][Full Text] [Related]
16. Secreted protein acidic and rich in cysteine (SPARC) exacerbates colonic inflammatory symptoms in dextran sodium sulphate-induced murine colitis. Ng YL; Klopcic B; Lloyd F; Forrest C; Greene W; Lawrance IC PLoS One; 2013; 8(10):e77575. PubMed ID: 24204877 [TBL] [Abstract][Full Text] [Related]
17. CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. Bassaganya-Riera J; Hontecillas R Clin Nutr; 2006 Jun; 25(3):454-65. PubMed ID: 16698153 [TBL] [Abstract][Full Text] [Related]
18. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Yu QT; Saruta M; Avanesyan A; Fleshner PR; Banham AH; Papadakis KA Inflamm Bowel Dis; 2007 Feb; 13(2):191-9. PubMed ID: 17206665 [TBL] [Abstract][Full Text] [Related]
19. Soluble fibers and resistant starch ameliorate disease activity in interleukin-10-deficient mice with inflammatory bowel disease. Bassaganya-Riera J; DiGuardo M; Viladomiu M; de Horna A; Sanchez S; Einerhand AW; Sanders L; Hontecillas R J Nutr; 2011 Jul; 141(7):1318-25. PubMed ID: 21562241 [TBL] [Abstract][Full Text] [Related]